WILLIAM M PECKAT

Allopathic & Osteopathic Physicians|Family Medicine BRYANT, AR NPI 1609304526

General Payments — all program years on this page

$946.88

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 58
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $226.96 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $226.9613

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $44.663
PFIZER INC. $38.092
GlaxoSmithKline, LLC. $32.162
Boehringer Ingelheim Pharmaceuticals, Inc. $22.681
ABBVIE INC. $19.481
DEXCOM, INC. $18.811
Lilly USA, LLC $17.861
Astellas Pharma US Inc $16.961
Acerta Pharma LLC $16.261

By program year

Program yearAmountRecords
2020 $20.201
2021 $300.4019
2022 $153.3610
2023 $245.9615
2024 $226.9613

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104202225 AstraZeneca Pharmaceuticals LP $16.26 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105224989 ABBVIE INC. $19.48 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116008867 Amgen Inc. $13.97 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116399494 GlaxoSmithKline, LLC. $15.92 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116513571 GlaxoSmithKline, LLC. $16.24 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117652342 Amgen Inc. $16.74 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117652344 Amgen Inc. $13.95 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118077574 Boehringer Ingelheim Pharmaceuticals, Inc. $22.68 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131289747 PFIZER INC. $18.70 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131843306 PFIZER INC. $19.39 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135481569 Lilly USA, LLC $17.86 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139331946 Astellas Pharma US Inc $16.96 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153344515 Dexcom, Inc. $18.81 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.